Acetylsalicylic Acid [50-78-2]
A0819
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAcetylsalicylic Acid [50-78-2]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionNSAID; COX-1/2 inhibitor.; Salicylic acid acetate; aspirin
- UNSPSC12352200
References
- Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012 May;13(5):518-27. PMID: 22440112. Bartfai T, Conti B. Fever. ScientificWorldJournal. 2010 Mar 16;10:490-503. PMID: 20305990. Antithrombotic Trialists' (ATT) Collaboration: Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30;373(9678):1849-60. PMID: 9482214. Tohgi H, Konno S, Tamura K, et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 1992 Oct;23(10):1400-3. PMID: 1412574. Li W, Li J, Ashok M, et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attentuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol. 2007 Mar 15;178(6):3856-3864. PMID: 17339485.